FDA Drug Application (021301) for LEVOXYL by KING PHARMS R AND D

Back to FDA Applications sponsored by KING PHARMS R AND D

Application Number021301
Product Number001
FormTABLET;ORAL
Dosage0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1,AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLEVOXYL
Active IngredientLEVOTHYROXINE SODIUM



Back to FDA Applications sponsored by KING PHARMS R AND D

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.